Adherent cells from placenta and use of same in disease treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 7, 2020
Grant Date -
Mar 3, 2016
app pub date -
Aug 25, 2015
filing date -
Nov 30, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods for treating conditions by administration of placenta derived adherent stromal cells to a subject in thereof are provided. Such conditions include skeletal muscle defects, neuropathic pain, and myocardial infarction. Also provided are methods wherein the adherent stromal cells administered are cultured under 2 dimensional or 3 dimensional growth conditions. Also provided are methods in which the cells administered are at least 70% adherent cells from a maternal or fetal portion of the placenta.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully